期刊文献+

纳米羟基磷灰石对肝癌细胞端粒酶基因表达的影响 被引量:1

Effect of HAP Nanoparticles on the Expression of Telomerase Gene of Hepatocellular Carcinoma Cells
下载PDF
导出
摘要 研究羟基磷灰石(HAP)纳米粒子对Bel-7402人肝癌细胞端粒酶基因表达的影响。采用均相沉淀法制备出稳定单分散的HAP纳米粒子,应用透射电镜、电位粒度仪对其进行表征。HAP纳米粒子作用Bel-7402肝癌细胞4 h后,采用原位杂交技术检测Bel-7402肝癌细胞的端粒酶基因表达。结果表明HAP纳米粒子作用组的Bel-7402肝癌细胞的端粒酶阳性细胞比例为61.38%,而对照组的端粒酶阳性细胞比例为87.89%,2组有显著性差异(P<0.01)。HAP纳米粒子可使Bel-7402肝癌细胞的端粒酶基因表达下调。 To investigate effect of HAP nanopaiticles on telomerase activation of the hepatoma cells. HAP nanoparticles were synthesized with homogeneous precipitation method and surveyed by TEM and Zataplus. After treated the hepatocellutar carcinoma Cells with HAP nanoparticles for 4 hours, the expression of telomerase gene of hepatocellular carcinoma Bel-7402 cells was detected by technique of hybridization in situ. The ratio of hepatocellular carcinoma Cells which telomerase gene expression was positive was 61.38%, and that of contral group was 87.89%, compared with control group(P〈0.01 ). HAP nanopaiticles could reduce expression of telomerase gene of hepatocellular carcinoma Bel-7402 cells.
出处 《武汉理工大学学报》 EI CAS CSCD 北大核心 2007年第5期46-48,共3页 Journal of Wuhan University of Technology
关键词 羟基磷灰石纳米粒子 肝癌细胞 端粒酶 原位杂交 hydroxyapatite nanoparticles hepatocellular carcinoma cell telomerase in situ hybridization
  • 相关文献

参考文献5

  • 1Labhasetwar V,Song C X,Levy R J.Nanoparticles Drug Delivery System for Restenosis[J].Adv Durg Deliv Rev,1997,24:63-85.
  • 2Feng L Y,Li S P,Yan Y H,et al.Inhibition of HAP Nanoparticles on W-256 Sarcoma of Rats on Vivo[J].Chinese Journal of Miomedical Engineering,2001,302-306.
  • 3任建国,周军,戴尧仁.端粒及端粒酶的研究进展[J].生物化学与生物物理进展,1999,26(5):415-415. 被引量:14
  • 4何冬梅,张洹.端粒酶活性的抑制对顺铂诱导HL-60细胞凋亡的影响[J].中国实验血液学杂志,2001,9(3):215-219. 被引量:3
  • 5Feng J,Funk W D,Wang S S,et al.The RNA Component of Human Telomerase[J].Science,1995,269:1236-1241.

二级参考文献12

  • 1Lee H W,Nature,1998年,392卷,6676期,569页
  • 2Kim J H,Plant Mol Biol,1998年,36卷,5期,661页
  • 3Bianchi A,EMBO J,1997年,16卷,7期,1785页
  • 4Kim NW, Piatyszek MA, Prowse KR, et al. Specific association of human telomerase activity with immortal cells and cancer. Science, 1994; 266: 2011 - 2015
  • 5Feng J, Funk WD, Wang SS, et al. The RNA component of human telomerase. Science, 1995; 269:1236- 1241
  • 6Kondo S, Tanaka Y, Kondo Y, et al. Antisense telomerase treatment: induction of two distinct pathways, apoptosis and differentiation. FASEB J, 1998; 12:801-811
  • 7Bodnar AG, Ouellette M, Frolkis M, et al. Extension of life-span by introduction of telomerase into normal human cells. Science, 1998; 279: 349 - 352
  • 8Kondo Y, Kondo S, Tanaka Y, et al. Inhibition of telomerase increases the susceptibility of human malignant glioblastoma cells to cisplatin-induced apoptosis. Oncogene, 1998;16: 2243 - 2248
  • 9Mandal M, Kumar R. Bcl-2 modulates telomerase activity.J Biol Chem, 1997; 272:14183 - 14187
  • 10Greenberg RA, O' Hagan RC, Deng H, et al. Telomerase reverse transcriptase gene is a direct target of c-Myc but is not functionally equivalent in cellular transformation. Oncogene, 1999; 18:1219-1226

共引文献15

同被引文献12

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部